Vanguard Global Advisers’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
GJL
Vanguard Global Advisers's CLB Position: Q3 2026 in Review
Vanguard Global Advisers increased its Core Laboratories (CLB) stake by 1.3% in Q3 2026, buying an estimated $2.62K and bringing the position to 17,305 shares worth $168K. The position accounts for ﹤0.01% of the portfolio, ranked #2548.
Vanguard Global Advisers first reported a position in CLB in Q1 2026 and has held it in 3 quarters since. The position peaked at $330K in Q1 2026. 179 funds tracked by Wall St. Rank hold CLB as of Q3 2026.
- Vanguard Global Advisers held 17,305 shares of Core Laboratories worth $168K as of Q3 2026.
- Vanguard Global Advisers bought 226 Core Laboratories shares in Q3 2026, an estimated $2.62K.
- Core Laboratories made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #2548 holding.
- Vanguard Global Advisers first reported a position in Core Laboratories in Q1 2026 and has held it in 3 quarters since.
- Vanguard Global Advisers's Core Laboratories position peaked at $330K in Q1 2026.
- 179 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.